Dáil Éireann Debate, Tuesday - 27 July 2021
1903. Deputy Michael Fitzmaurice asked the Minister for Health when he expects an inquiry will be established to investigate the historical licensing and prescribing of sodium valproate to pregnant women without them being made aware of the impacts it could have on their child; and if he will make a statement on the matter. [35803/21]
View answer1917. Deputy Seán Canney asked the Minister for Health the status of the promised inquiry into anti-epilepsy drug sodium valproate; and if he will make a statement on the matter. [35863/21]
View answer1922. Deputy Catherine Connolly asked the Minister for Health the status of the inquiry into the historical licensing and use of sodium valproate in Ireland; when the terms of reference will be published; the status of the establishment of a stakeholder group to address ongoing concerns relating to the use of sodium valproate; the membership of the stakeholder group; and if he will make a statement on the matter. [35875/21]
View answer1931. Deputy Denise Mitchell asked the Minister for Health the status of inquiry into anti-epilepsy drug sodium valproate which has been committed to; and if he will make a statement on the matter. [35886/21]
View answer2019. Deputy Joe O'Brien asked the Minister for Health the proposed establishment of an inquiry into the historical licensing and use of sodium valproate in Ireland; and if he will make a statement on the matter. [36227/21]
View answerI propose to take Questions Nos. 1903, 1917, 1922, 1931 and 2019 together.
Details of the proposed inquiry into the historical licensing and use of sodium valproate in Ireland, and of the proposed stakeholder group, are currently being considered by officials within the Department of Health.
